Opko Health announced earlier that Novitas Solutions issued a draft local coverage determination for the 4Kscore test. The draft LCD is a proposed non-coverage policy for the 4Kscore test for Medicare and, prior to its effectiveness, is subject to a public comment period ending July 5, the company said. OPKO plans to submit comments during this time period. Shares of Opko Health are down 19%, or 94c, to $3.94 in morning trading. The company noted that 4Kscore test has been included in the National Comprehensive Cancer Network Guidelines since 2015, and European Association of Urology Prostate Cancer Guidelines since 2016. Novitas Solutions is an administrative services processing company for government-sponsored health care programs on behalf of the federal government, including the Centers for Medicare and Medicaid Services. Novitas serves as the Medicare Administrative Contractor for a jurisdiction that includes the State of New Jersey, where Opko’s BioReference Laboratories is located and where all 4Kscore test samples are processed.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.